期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間： 一般,3-6周

Antioxidants & Redox Signaling (ARS) is the leading peer-reviewed journal dedicated to understanding the vital impact of oxygen and oxidation-reduction (redox) processes on human health and disease. The Journal explores key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas.

ARS has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics. ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research. ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes.

ARS coverage includes:

-ROS/RNS as messengers

-Gaseous signal transducers

-Hypoxia and tissue oxygenation

-microRNA

-Prokaryotic systems

-Lessons from plant biology

《抗氧化劑與氧化還原信號(hào)》（ARS）是領(lǐng)先的同行評(píng)審期刊，致力于了解氧氣和氧化還原（氧化還原）過(guò)程對(duì)人類(lèi)健康和疾病的重要影響。該期刊探討遺傳、藥物和營(yíng)養(yǎng)氧化還原療法中的關(guān)鍵問(wèn)題。前沿研究側(cè)重于結(jié)構(gòu)生物學(xué)、干細(xì)胞、再生醫(yī)學(xué)、表觀遺傳學(xué)、成像、臨床結(jié)果以及預(yù)防和治療營(yíng)養(yǎng)等領(lǐng)域。

ARS 已擴(kuò)展為在一本期刊中創(chuàng)建兩個(gè)獨(dú)特的焦點(diǎn)：ARS Discoveries 和 ARS Therapeutics。ARS Discoveries（24 期）發(fā)表基礎(chǔ)和應(yīng)用研究領(lǐng)域中最高水平的突破性成果。 ARS Therapeutics（共 12 期）是同類(lèi)出版物中的第一本，它將通過(guò)展示氧化還原科學(xué)改變健康結(jié)果的潛力，幫助提升整個(gè)氧化還原生物學(xué)領(lǐng)域。

ARS 報(bào)道包括：

-ROS/RNS 作為信使

-氣體信號(hào)傳感器

-缺氧和組織氧合

-microRNA

-原核系統(tǒng)

-植物生物學(xué)的經(jīng)驗(yàn)教訓(xùn)

《Antioxidants & Redox Signaling》(抗氧化劑和氧化還原信號(hào))編輯部通訊方式為MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801。如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢(xún)我們的客服老師。我們專(zhuān)注于期刊咨詢(xún)服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。